Associate Medical Director, Global Apheresis
Specialist in Therapeutic Plasma Exchange & Full-Spectrum Apheresis – Advancing precision care for longevity, Alzheimer's, inflammation, and autoimmune disorders.
Therapeutic Plasma Exchange (TPE) is a medical procedure that filters and replaces blood plasma to remove harmful circulating factors — from autoantibodies to inflammatory proteins to environmental toxins. It's one of the most versatile treatments in medicine, with over 80 recognized clinical applications.
Learn more →Removes inflammatory molecules, oxidized proteins, and senescent factors that accumulate with age.
Restores optimal signaling between organs, resetting metabolic, immune, and regenerative systems.
Albumin replacement provides powerful antioxidant and anti-inflammatory effects throughout the body.
Fresh plasma awakens dormant stem cells, enhancing your body’s natural regenerative capacity.
Patients report increased energy, improved cognition, and enhanced physical performance.
Addresses underlying inflammatory and degenerative processes to prevent and manage chronic disease.
The AMBAR trial showed TPE slowed cognitive decline by 52–71% — with zero risk of ARIA.
Learn more →The Buck Institute measured a 2.61-year biological age reduction using 35 epigenetic clocks.
Learn more →TPE is first-line treatment for over a dozen autoimmune conditions — backed by ASFA Category I evidence.
Learn more →PFAS, microplastics, mold. When toxins bind to blood proteins, TPE removes them at the source.
Learn more →Board-Certified Clinical Pathologist & Apheresis Specialist
Board-certified in Clinical Pathology. Associate Medical Director at Global Apheresis. Trained under Dr. Dobri Kiprov, one of the physicians who established TPE as a clinical discipline.
Read full bio →Peer-reviewed contributions spanning hematology, apheresis medicine, and transfusion science.
Blood Vessels, Thrombosis & Hemostasis
Demonstrates a personalized approach to caplacizumab dosing guided by ADAMTS13 activity monitoring, optimizing treatment outcomes in iTTP.
View PaperJournal of Clinical Apheresis
Case report demonstrating successful use of therapeutic plasma exchange for managing hyperviscosity syndrome in juvenile rheumatoid arthritis.
View PaperAnnals of Hematology
First reported use of lenalidomide for refractory acquired von Willebrand disease in the setting of monoclonal gammopathy.
View Paper
The honest pricing breakdown most clinics won't give you. What TPE actually costs, what you're paying for, and why the range is so wide.
Read More →
Joe Rogan posted about receiving plasmapheresis. Here are the clinical answers to the questions everyone is asking — from a physician who supervises TPE every week.
Read More →
If you're investing in stem cell therapy, exosomes, or PRP, the environment those therapies enter matters as much as the therapies themselves. Here's the clinical case for sequencing TPE first.
Read More →Book a discovery call to discuss how Therapeutic Plasma Exchange can help you achieve your health and longevity goals. Virtual and in-person options available.
